In Vitro Acid Resistance of Pathogenic Candida Species in Simulated Gastric Fluid
- PMID: 39996247
- PMCID: PMC11847298
- DOI: 10.1016/j.gastha.2024.100591
In Vitro Acid Resistance of Pathogenic Candida Species in Simulated Gastric Fluid
Abstract
Background and aims: Although species in the fungal genus Candida are often commensal residents of the gastrointestinal (GI) tract, they can also cause high-mortality systemic candidiasis. Most pathogenic Candida species are dimorphic fungi that exist predominantly in filamentous forms in the invading tissues. Candida albicans is the most prominent pathogen among Candida species, but nonalbicans Candida species have also emerged as important pathogens. The stomach is the most acidic niche in the GI tract and is maintained at pH 1-2 in healthy individuals. The aim of the present study was to determine whether Candida species can survive in gastric fluid and to observe their morphology under varied pH conditions.
Methods: We investigated the in vitro survival of the pathogenic Candida species C. albicans, Candida glabrata, Candida parapsilosis, and Candida tropicalis in simulated gastric fluid.
Results: We first described that a portion of the 4 Candida species can survive under highly acidic conditions. Moreover, dimorphic Candida species, namely, C. albicans, C. parapsilosis, and C. tropicalis, exhibited yeast-hyphal transition in simulated gastric fluid with elevated pH. Pathogenic filamentous cells had lower acid resistance than yeast cells.
Conclusion: These findings may illuminate the migration to the lower GI tract by commensal fungi of the oral cavity.
Keywords: Artificial Gastric Juice; Candida Albicans; Candida Glabrata; Candida Parapsilosis; Candida Tropicalis.
© 2024 The Authors.
Figures





Similar articles
-
Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.J Oral Pathol Med. 2006 Sep;35(8):484-91. doi: 10.1111/j.1600-0714.2006.00435.x. J Oral Pathol Med. 2006. PMID: 16918600
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.Med Mycol. 2009 Nov;47(7):681-9. doi: 10.3109/13693780802549594. Med Mycol. 2009. PMID: 19888800
-
Survival Strategies of Pathogenic Candida Species in Human Blood Show Independent and Specific Adaptations.mBio. 2020 Oct 6;11(5):e02435-20. doi: 10.1128/mBio.02435-20. mBio. 2020. PMID: 33024045 Free PMC article.
-
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.J Hosp Infect. 2002 Apr;50(4):243-60. doi: 10.1053/jhin.2001.1151. J Hosp Infect. 2002. PMID: 12014897 Review.
Cited by
-
Invasive Gastric Candidiasis With Concurrent Clostridioides difficile Colitis: A Case Report and Review of the Literature.Cureus. 2025 Jul 16;17(7):e88115. doi: 10.7759/cureus.88115. eCollection 2025 Jul. Cureus. 2025. PMID: 40821331 Free PMC article.
References
-
- McCarty T.P., Pappas P.G. Invasive candidiasis. Infect Dis Clin. 2016;30:103–124. - PubMed
-
- Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317. - PubMed
-
- Silva S., Negri M., Henriques M., et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36:288–305. - PubMed
LinkOut - more resources
Full Text Sources